BioSpace News Archive

Pharm Country

Cancer Genetics Receives Non-Dilutive Funding of $1.1M Through New Jersey Technology Business Tax Certificate Transfer (NOL) Program

The payment, received in December 2017, is net of administrative and sales expenses and fees associated with the program.

December 28, 2017
·
3 min read
Policy

Veritas Pharma Subsidiary Receives Health Canada Dealer Licence

This is a significant step for CTL in that in conjunction with discovering and developing new therapeutic cannabis strains.

December 28, 2017
·
3 min read
Deals

Endonovo Therapeutics Provides Update on Acquisition of PEMF Assets, Clinical Pipeline and Pre-Clinical Study

The Company is currently in the process of transferring all of the assets it has acquired from Rio Grande Neurosciences and registering with the FDA to become regulatory compliant.

December 28, 2017
·
6 min read
Emerald Health Therapeutics Awards Stock Options

The Options have been granted pursuant to the Company’s Omnibus Incentive Plan which has been previously approved by the Company’s shareholders and the TSX Venture Exchange.

December 28, 2017
·
2 min read
Deals

Digirad Announces Sale of Its MDSS Service Contracts to Philips North America

Total consideration under the Agreement is $8 million.

December 28, 2017
·
2 min read
The Financial Calendar of AS Olainfarm for 2018 - Dec. 28, 2017

Olainfarm will publish its reports on following dates in 2018.

December 28, 2017
·
1 min read
Policy

TherapeuticsMD Announces Submission of New Drug Application for TX-001HR

The NDA submission is supported by the complete TX-001HR clinical program, including positive results of the recently completed phase 3 Replenish Trial.

December 28, 2017
·
4 min read
Drug Development

Adverum Biotechnologies Doses First Patient in the ADVANCE Phase I/II Clinical Trial of ADVM-043 for A1AT Deficiency

The ADVANCE clinical trial is designed to evaluate the safety and protein expression following a single administration of ADVM-043, Adverum’s novel gene therapy candidate.

December 28, 2017
·
5 min read
Shareholders Turn Down Tender Offer to Take BioCanCell Private

Approximately 5.9 million shares were necessary for the tender to be accepted.

December 28, 2017
·
2 min read
BioMidwest

Predictive Technology Group Announces Issuance of U.S. Patent for Method of Treating Endometriosis

The patent covers any treatment of endometriosis in women, whether symptomatic or not, having any one (or more) of approximately 1,400 endometriosis-associated midwegenetic markers.

December 28, 2017
·
2 min read